A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.

Hisashi TanakaChiori TabeFumihiko OkumuraToshihiro ShiratoriYoshiko IshiokaMasamichi ItogaKageaki TaimaTakeshi MorimotoDaisuke KimuraTakao TsushimaSadatomo Tasaka

Published in: Thoracic cancer (2020)

Carboplatin and oral S-1 had modest survival benefit but this regimen was not tolerable. Fatal pulmonary embolism occurred in this regimen.

Keyphrases

pulmonary embolism
inferior vena cava
phase ii study
lymph node
phase iii
clinical trial
radiation therapy
prognostic factors
locally advanced